课题基金 / 基金详情

Toxicity Study of the Perflourinated compounds

Toxicity Study of the Perflourinated compounds
全氟化合物的毒性研究
批准号:
8845108
负责人:
LU TAYLOR
金额:
$68.4万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-03 至 2015-02-02

项目摘要

项目成果

LU TAYLOR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of both of these contracts are to provide support of National Toxicology Program (NTP) hazard identification activities targeted toward the prevention of diseases or adverse effects caused by environmental exposure to chemical or physical agents. Toxicity testing is an important aspect of public health research in that it serves to identify chemicals that are hazardous to human health. Proper chemical analyses are required to ensure that, in toxicity studies, the test species are exposed to the prescribed chemicals at the specified dose concentrations. These contracts contribute to the ability of toxicity studies to provide evidence of heightened cancer risk along with other toxicological outcomes, by providing characterization of the chemicals studied, confirmation of the dose levels administered, and internal dose determinations. This information is critical to evaluation of toxicity tests and development of sound, scientific conclusions about the potential toxicity of the study chemical in the test species and ultimately supports the risk assessment efforts of National Toxicology Program and other federal agencies. With internal dose information provided by this contract, extrapolations to humans can be made so that the public can be adequately informed about risk factors arising from exposure to studied chemicals. Both of these contracts are used for determining the toxicological potential of selected test agents for the National Toxicology Program (NTP).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Toxicity study of n-butylbenzenesulfonamide (NBBS)
Toxicity Study of the Ionic Liquids
Studies to Evaluate Cardiotoxic Disease Process in Three Strains of Mice Exposed
Age Related Survival and Spontaneous Disease Phenotype in Selected Genetically Di
海外基金